… health system, but still, brain diseases like brain tumour have remained formidable owing to
… the brain tissue. In this review, we highlighted the application and potential of NLCs in brain-…

… brain barrier (BBB) and blood-brain tumour barrier (BBTB) pose a significant challenge to
drug delivery to brain tumours… designed functional nanostructured lipid carriers (NLC) to tailor …

… Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) comprise a … blood
brain barrier (BBB). In this review, a presentation of the most important brain diseases (brain …

… by changing the concentrations or combining liquid lipids (Labrasol, Lauroglycol 90, … brain
barrier (BBB). For the treatment of glioblastoma, the authors used 3D BBB/blood–brain tumour …

… of lipid nanostructures to combat brain tumors. In addition, this review summarizes the literature
pertaining to solid lipid nanoparticles (SLN) and nanostructured lipid carriers … blood brain …

… The treatment of a brain tumour via SLNs is gaining greater … of SLNs in the brain tumour
treatment with appropriate … BCNU-coated lipid carriers were administrated through the IV …

… ) internalisation into brain tumour cells was developed by the use of lipid nanocapsules (LNCs) …
-TBS.40–63 peptide as an active ligand for peripheral drug delivery to the brain tumours. …

… [7] proposed NLCs as enhanced SLNs through mixing the solid lipids with liquid lipids which
… importance of solid lipid nanoparticles and nanostructured lipid carriers in GBM treatment, …

… Brain tumours are among the most feared of all forms of … primary brain tumour is a type of
astrocytoma (a tumour that … At the end of the 90’s, nanostructured lipid carriers (NLCs) were …

… , solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), to target brain
tumors. But, it is worthwhile to discuss first the barriers for brain anticancer drug delivery. …